Back to company

PHARMAORIGIN ApS: Financial statements 2015

CVR: 29178291

PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -135,000 compared with DKK -558,000 the year before. Equity amounted to DKK 4,175,000. The solvency ratio was 60%.

Profit/Loss
-135,000 kr.
Equity
4,175,000 kr.
Total Assets
6,957,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015---135 t.4.2 mio.-
2014---558 t.4.3 mio.-
201300-938 t.-132 t.-
2012---149 t.806 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2015

PHARMAORIGIN ApS: The 2014 annual report is outJun 11, 2015

PHARMAORIGIN ApS has published its annual report for 2014. The net result was DKK -558,000.

Søren Bech Justesen joins PHARMAORIGIN ApS as directorJun 1, 2015

As of June 1, 2015, Søren Bech Justesen is registered as director of PHARMAORIGIN ApS.

About PHARMAORIGIN ApS

PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.